He also articulated a very specific doctrine about the role of an FDA commissioner, one that is limited in its power and ...
The FDA granted priority review to a new drug application for sunvozertinib as an oral treatment for certain patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback